CardioGenics Holdings Inc (CGNH)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Aug 13, 2025, 8:00 PM EDT
CardioGenics Holdings Market Cap
CardioGenics Holdings has a market cap or net worth of $143.00 as of August 15, 2025. Its market cap has decreased by -100.00% in one year.
Market Cap
143.00
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since August 3, 2009, CardioGenics Holdings's market cap has decreased from 90.05M to 143.00, a decrease of -100.00%. That is a compound annual growth rate of -56.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 143.00 | -99.50% |
| Dec 29, 2022 | 28.57K | 100.00% |
| Dec 31, 2021 | 14.29K | -99.43% |
| Dec 31, 2020 | 2.50M | 98.86% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.72M |
| Veradigm | 789.71M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 608.19M |
| Glass House Brands | 543.74M |
| American Oncology Network | 393.37M |
| Northwest Biotherapeutics | 332.06M |
| CytoDyn | 300.87M |